prodromal

A solution for improving recruitment into early Alzheimer’s disease clinical trials

Insights Back to resource centre 12 April 2018 A solution for improving recruitment into early Alzheimer’s disease clinical trials Screening patients into early stage Alzheimer’s trials can be costly and time-consuming. Kenton Zavitz, PhD, Director of Clinical Affairs proposes a potential solution for improving recruitment into clinical trials. Key pointsScreening patients into early Alzheimer’s trials can be costly and time-consuming.Screening

A solution for improving recruitment into early Alzheimer’s disease clinical trials Read More »

The challenge of detecting early Alzheimer’s disease for clinical trials

Insights Back to resource centre 9 April 2018 The challenge of detecting early Alzheimer’s disease for clinical trials In this post, Director of Clinical Affairs, Dr Kenton Zavitz, looks at the challenge of recruiting the correct patients into Alzheimer’s disease trials. Key PointsAlzheimer’s disease (AD) is a global healthcare and economic crisis.Despite hundreds of clinical trials of new AD treatments,

The challenge of detecting early Alzheimer’s disease for clinical trials Read More »

Scroll to Top